Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel

A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 100 participants.

Also called NCT02925923

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 100 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02925923
Other papers using this trial's data
  • Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial Journal of the American Heart Association, 2019-12-03 DOI, PubMed 31766977, PMC6912971 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02925923. Randomized; no masking; primary purpose treatment. Start 2016-11-01 (actual); primary completion 2018-01-30 (actual). Results posted on 2020-05-04.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Crushed Ticagrelor Versus Eptifibatide Bolus + Clopidogrel
Condition
Acute Coronary Syndrome
Condition
Angina, Unstable
Intervention (Drug)
Ticagrelor
Intervention (Drug)
Eptifibatide
Intervention (Drug)
Clopidogrel
Lead sponsor
University of Alabama at Birmingham (class: other)

Record details

Record id
cardio:ct-nct02925923
Content hash
a1bab28b5c7927352b0b1ac042a1900ea4e825767e94382a7ce8a05f6507230a